Baxter Healthcare Corp. recalls Brevibloc DOUBLE STRENGTH Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2000mg/100mL (20 mg/mL), 100 mL…
- Recall date
- April 12, 2016
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0852-2016
- FDA classification
- Class II
- Brand / firm
- Baxter Healthcare Corp.
- Sold / distributed
- Nationwide
Why it was recalled
Discoloration: presence of atypical yellow discoloration of the solution .
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Brevibloc DOUBLE STRENGTH Premixed Injection, Esmolol Hydrochloride in Sodium Chloride, 2000mg/100mL (20 mg/mL), 100 mL, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, Il 60015, NDC 10019-075-87
Get recall alerts
Free email alert whenever Baxter Healthcare Corp. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Baxter Healthcare Corp.